- Home
- / Onconova Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Onconova Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.6
2024-06-03
Market Capitalization
$20.9 M
2024-06-03
Revenue
$2.8 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.8M | 800.0K | 11.5M | 5.5M | 787.0K | 1.2M | 2.2M | 231.0K | 226.0K | 226.0K | 226.0K | 226.0K | 2.8M |
| General and administrative expense | 16.8M | 15.1M | 9.5M | 9.2M | 7.4M | 7.6M | 8.3M | 8.3M | 9.4M | 8.4M | 9.1M | 12.3M | 8.5M |
| Operating expense total | 67.0M | 64.5M | 35.4M | 29.2M | 26.5M | 24.5M | 23.9M | 25.2M | 19.9M | 25.1M | 20.7M | ||
| EBIT | (62.2M) | (63.7M) | (24.0M) | (23.7M) | (25.7M) | (23.3M) | (21.7M) | (25.0M) | (16.5M) | (19.6M) | (20.3M) | (142.4M) | (17.9M) |
| EBIT margin, % | -1309.1% | -7968.0% | -209.3% | -427.4% | -3270.3% | -1895.9% | -994.0% | -10819.5% | -8684.5% | -62997.3% | -640.7% | ||
| Interest income | 1.4M | 510.0K | |||||||||||
| Pre tax profit | (62.1M) | (63.8M) | (24.0M) | (19.7M) | (24.1M) | (20.5M) | (21.5M) | (25.2M) | (16.2M) | (19.0M) | (18.9M) | (166.5M) | 9.2M |
| Income tax expense | 435.0K | 19.0K | 16.0K | 14.0K | 13.0K | (124.0K) | 10.0K | 4.0K | |||||
| Net Income | (62.5M) | (63.7M) | (24.0M) | (19.7M) | (24.1M) | (20.6M) | (21.5M) | (25.2M) | (16.2M) | (19.0M) | (18.9M) | (166.5M) | 9.2M |
| EPS | (0.9) | (35.2) | 0.8 |